title: The challenging patient with varicella-zoster virus disease.
abstract: Varicella-zoster virus (VZV) reactivation from latently infected ganglia causes multiple neurologic diseases. The most common is herpes zoster, which is frequently complicated by postherpetic neuralgia, meningoencephalitis, and vasculopathy, including VZV temporal arteritis, myelopathy, and retinal necrosis. All of these disorders can develop without rash. Importantly, VZV vasculopathy is emerging as a significant cause of TIAs and stroke. In particular, a subset of patients who present with symptoms and signs of giant cell arteritis (GCA), but whose temporal artery biopsies are GCA-negative, have multifocal VZV vasculopathy with temporal artery infection. Herein we focus on the specific diagnostic and therapeutic challenges that clinical neurologists encounter in diseases caused by VZV, discuss guidelines for zoster vaccine, and highlight molecular features of VZV latency with a focus on preventing the serious neurologic and ocular complications of VZV reactivation.
authors.affiliation: Departments of Neurology (MAN, DG) and Microbiology (DG), University of Colorado School of Medicine, Aurora.
authors.forename: Maria A
authors.initials: MA
authors.lastname: Nagel
authors.forename: Don
authors.initials: D
authors.lastname: Gilden
references.citation: J Neurol Sci. 2012 Dec 15;323(1-2):245-7
references.pmid: 22935406
references.citation: Lancet Neurol. 2003 Sep;2(9):567-71
references.pmid: 12941580
references.citation: J Neurovirol. 1995 Mar;1(1):130-3
references.pmid: 9222350
references.citation: J Infect Dis. 1998 Nov;178 Suppl 1:S109-12
references.pmid: 9852987
references.citation: Neurology. 2010 Mar 9;74(10):792-7
references.pmid: 20200348
references.citation: J Virol. 2011 Mar;85(5):2276-87
references.pmid: 21177814
references.citation: Neurology. 2008 Mar 11;70(11):853-60
references.pmid: 18332343
references.citation: N Engl J Med. 2005 Jun 2;352(22):2271-84
references.pmid: 15930418
references.citation: Neuromodulation. 2011 Jan;14(1):58-61; discussion 61
references.pmid: 21992163
references.citation: J Virol. 2012 Sep;86(18):10203-6
references.pmid: 22740396
references.citation: J R Coll Gen Pract. 1975 Aug;25(157):571-5
references.pmid: 1195231
references.citation: Arch Neurol. 2006 Jul;63(7):940-2
references.pmid: 16682531
references.citation: Neurology. 2013 Jan 8;80(2):220-2
references.pmid: 23255829
references.citation: Pain. 1991 Feb;44(2):105-117
references.pmid: 1711192
references.citation: Ann Neurol. 1994 May;35(5):530-3
references.pmid: 8179298
references.citation: Arch Neurol. 2011 Apr;68(4):517-20
references.pmid: 21482932
references.citation: Virology. 1999 Jun 5;258(2):451-4
references.pmid: 10366583
references.citation: Br Med J. 1958 Aug 16;2(5093):418-21
references.pmid: 13560886
references.citation: Surg Neurol. 1978 Jul;10(1):50-3
references.pmid: 684607
references.citation: Proc Natl Acad Sci U S A. 1988 Apr;85(8):2767-70
references.pmid: 2833752